Search

Your search keyword '"Meerpohl, Joerg J."' showing total 935 results
Start Over Author "Meerpohl, Joerg J."
935 results on '"Meerpohl, Joerg J."'

1. Infection control, prophylactic antibiotics, and testing for SARS-CoV-2 and PPE on German intensive care units: results from a national mixed methods survey

Author

Dickel, Steffen, Grimm, Clemens, Popp, Maria, Struwe, Claudia, Sachkova, Alexandra, Golinski, Martin, Seeber, Christian, Fichtner, Falk, Heise, Daniel, Kranke, Peter, Meissner, Winfried, Laudi, Sven, Voigt-Radloff, Sebastian, Meerpohl, Joerg J., Jabs, Jonas, Mutters, Nico T., Moerer, Onnen, and German CEOsys Study Group

Subjects
covid-19, ppe, prophylactic antibiotics, variants of concern, cohort isolation, Medicine, Public aspects of medicine, RA1-1270, Microbiology, QR1-502
Abstract

Aim: Recommendations on hygiene measures, personal protective equipment (PPE), isolation, and antibiotic prophylaxis were developed during the coronavirus 2019 disease (COVID-19) pandemic and have been revised several times to date. Some of the underlying literature indicates a large evidence gap. We suspect that this leads to a large variance of measures on German intensive care units (ICU).Methods: A mixed methods online survey among intensive-care specialists in Germany caring for COVID-19 patients was conducted in December 2020.Results: We received responses from 205 German ICUs that had treated COVID-19 patients to date. There was wide variation in the use of PPE. Polymerase Chain reaction (PCR) testing for (SARS-CoV-2) was used by 94.8% of the units, with an average waiting time of 12 hours for the result. 18.7% of the respondents prescribed antibiotic prophylaxis in COVID-19 patients.Conclusion: We found a high variance in essential care strategies for COVID-19 patients on German intensive care units. This included differences in infection prophylaxis, personal protective equipment, and the indication of prophylactic antibiotic therapy. Based on our results, we recommend further studies to quantify and improve guideline adherence.

Published
2021
Full Text
View/download PDF

2. Informing pandemic management in Germany with trustworthy living evidence syntheses and guideline development: lessons learned from the COVID-19 evidence ecosystem

Author

Kunzler, Angela M., Iannizzi, Claire, Burns, Jacob, Metzendorf, Maria-Inti, Voigt-Radloff, Sebastian, Piechotta, Vanessa, Schmaderer, Christoph, Holzmann-Littig, Christopher, Balzer, Felix, Benstoem, Carina, Binder, Harald, Boeker, Martin, Dirnagl, Ulrich, Fichtner, Falk, Golinski, Martin, Grundmann, Hajo, Hengel, Hartmut, Jabs, Jonas, Kern, Winfried V., Kopp, Ina, Kranke, Peter, Kreuzberger, Nina, Laudi, Sven, Lichtner, Gregor, Lieb, Klaus, Maun, Andy, Moerer, Onnen, Müller, Anika, Mutters, Nico T., Nothacker, Monika, Pfadenhauer, Lisa M., Popp, Maria, Rüschemeyer, Georg, Schmucker, Christine, Schwingshackl, Lukas, Spies, Claudia, Steckelberg, Anke, Stegemann, Miriam, Strech, Daniel, von Dincklage, Falk, Weibel, Stephanie, Wunderlich, Maximilian Markus, Zöller, Daniela, Rehfuess, Eva, Skoetz, Nicole, and Meerpohl, Joerg J.

Published
2024
Full Text
View/download PDF

3. A tool to assess risk of bias in non-randomized follow-up studies of exposure effects (ROBINS-E)

Author

Higgins, Julian P.T., Morgan, Rebecca L., Rooney, Andrew A., Taylor, Kyla W., Thayer, Kristina A., Silva, Raquel A., Lemeris, Courtney, Akl, Elie A., Bateson, Thomas F., Berkman, Nancy D., Glenn, Barbara S., Hróbjartsson, Asbjørn, LaKind, Judy S., McAleenan, Alexandra, Meerpohl, Joerg J., Nachman, Rebecca M., Obbagy, Julie E., O'Connor, Annette, Radke, Elizabeth G., Savović, Jelena, Schünemann, Holger J., Shea, Beverley, Tilling, Kate, Verbeek, Jos, Viswanathan, Meera, and Sterne, Jonathan A.C.

Published
2024
Full Text
View/download PDF

5. Public information needs and preferences on COVID-19: a cross-sectional study

Author

Lühnen, Julia, Frese, Thomas, Mau, Wilfried, Meyer, Gabriele, Mikolajczyk, Rafael, Richter, Matthias, Schildmann, Jan, Braunisch, Matthias C., Fichtner, Falk, Holzmann-Littig, Christopher, Kranke, Peter, Popp, Maria, Schaaf, Christian, Schmaderer, Christoph, Seeber, Christian, Werner, Anne, Wijnen-Meijer, Marjo, Meerpohl, Joerg J., and Steckelberg, Anke

Published
2023
Full Text
View/download PDF

6. Lessons Learnt: Undertaking Rapid Reviews on Public Health and Social Measures during a Global Pandemic

Author

Rehfuess, Eva A., Burns, Jacob B., Pfadenhauer, Lisa M., Krishnaratne, Shari, Littlecott, Hannah, Meerpohl, Joerg J., and Movsisyan, Ani

Abstract

Public health and social measures (PHSM) have been central to the COVID-19 response. Consequently, there has been much pressure on decision-makers to make evidence-informed decisions and on researchers to synthesize the evidence regarding these measures. This article describes our experiences, responses and lessons learnt regarding key challenges when planning and conducting rapid reviews of PHSM during the COVID-19 pandemic. Stakeholder consultations and scoping reviews to obtain an overview of the evidence inform the scope of reviews that are policy-relevant and feasible. Multiple complementary reviews serve to examine the benefits and harms of PHSM across different populations and contexts. Conceiving reviews of effectiveness as adaptable living reviews helps to respond to evolving evidence needs and an expanding evidence base. An appropriately skilled review team and good planning, coordination and communication ensures smooth and rigorous processes and efficient use of resources. Scientific rigor, the practical implications of PHSM-related complexity and likely time savings should be carefully weighed in deciding on methodological shortcuts. Making the best possible use of modeling studies represents a particular challenge, and methods should be carefully chosen, piloted and implemented. Our experience raises questions regarding the nature of rapid reviews and regarding how different types of evidence should be considered in making decisions about PHSM during a global pandemic. We highlight the need for readily available protocols for conducting studies on the effectiveness, unintended consequences and implementation of PHSM in a timely manner, as well as the need for rapid review standards tailored to "rapid" versus "emergency" mode reviewing.

Published
2022
Full Text
View/download PDF

7. Subsequent Full Publication of Qualitative Studies Presented at United Kingdom Royal College of Nursing Research Conference 2015 and 2016: A Follow-Up Study

Author

Toews, Ingrid, Nyirenda, John L. Z., Stadelmaier, Julia, Schwarzer, Guido, Noyes, Jane, Booth, Andrew, Lewin, Simon, and Meerpohl, Joerg J.

Abstract

A considerable proportion of quantitative research remains unpublished once completed. Little research has documented non-dissemination and dissemination bias in qualitative research. This study aimed to generate evidence on the extent of non-dissemination in qualitative research. We followed a cohort of qualitative studies presented as conference abstracts to ascertain their subsequent publication status. We searched for subsequent full publication in MEDLINE, in the Cumulative Index to Nursing & Allied Health Literature and in Google Scholar. We matched abstracts to subsequent publications according to authors, method of data collection and phenomenon of interest. Fisher's exact test was calculated to examine associations between study characteristics and publication. Factors potentially associated with time to publication were evaluated with Cox regression analysis. For 91 of 270 included abstracts (33.70%; 95% CI 28.09%-39.68%), no full publication was identified. Factors that were found to be associated with subsequent full publication were oral presentation (OR 4.62; 95% CI 2.43-8.94) and university affiliation (OR 1.96; 95% CI 1.05-3.66). Compared to oral presentations, studies presented as posters took longer time to reach full publication (hazard ratio 0.35, 95% CI 0.21-0.58). This study shows that it was not possible to retrieve a full publication for over one-third of abstracts. Our findings suggest that where this non-dissemination is systematic, it may lead to distortions of the qualitative evidence-base for decision-making through dissemination bias. Our findings are congruent with those of other studies. Further research might investigate non-dissemination of qualitative studies in other disciplines to consolidate our findings.

Published
2022
Full Text
View/download PDF

10. Reevaluation of Statistically Significant Meta-Analyses in Advanced Cancer Patients Using the Hartung-Knapp Method and Prediction Intervals--A Methodological Study

Author

Siemens, Waldemar, Meerpohl, Joerg J., Rohe, Miriam S., Buroh, Sabine, Schwarzer, Guido, and Becker, Gerhild

Abstract

Using the Hartung-Knapp method and 95% prediction intervals (PIs) in random-effects meta-analyses is recommended by experts but rarely applied. Therefore, we aimed to reevaluate statistically significant meta-analyses using the Hartung-Knapp method and 95% PIs. In this methodological study, three databases were searched from January 2010 to July 2019. We included systematic reviews reporting a statistically significant meta-analysis of at least four randomized controlled trials in advanced cancer patients using either a fixed-effect or random-effects model. We investigated the impact of switching from fixed-effect to random-effects meta-analysis and of using the recommended Hartung-Knapp method in random-effects meta-analyses. Furthermore, we calculated 95% PIs for all included meta-analyses. We identified 6234 hits, of which 261 statistically significant meta-analyses were included. Our recalculations of these 261 meta-analyses produced statistically significant results in 132 of 138 fixed-effect and 114 of 123 random-effects meta-analyses. When switching to a random-effects model, 19 of 132 fixed-effect meta-analyses (14.4%) were no longer statistically significant. Using the Hartung-Knapp method in random-effects meta-analyses resulted in 34 of 114 nonsignificant meta-analyses (29.8%). In the full sample (N = 261), the "null effect" was included by the 95% PI in 195 (74.7%) and the "opposite effect" (e.g., hazard ratio 0.5, opposite effect 2) in 98 meta-analyses (37.5%). Using the Hartung-Knapp method and PIs substantially influenced the interpretation of many published, statistically significant meta-analyses. We strongly encourage researchers to check if using the Hartung-Knapp method and reporting 95% PIs is appropriate in random-effects meta-analyses.

Published
2022
Full Text
View/download PDF

11. American Society of Hematology 2021 guidelines for sickle cell disease: stem cell transplantation

Author

Kanter, Julie, Liem, Robert I, Bernaudin, Françoise, Bolaños-Meade, Javier, Fitzhugh, Courtney D, Hankins, Jane S, Murad, M Hassan, Panepinto, Julie A, Rondelli, Damiano, Shenoy, Shalini, Wagner, John, Walters, Mark C, Woolford, Teonna, Meerpohl, Joerg J, and Tisdale, John

Subjects
Biomedical and Clinical Sciences, Cardiovascular Medicine and Haematology, Stem Cell Research - Nonembryonic - Human, Rare Diseases, Clinical Research, Stem Cell Research, Hematology, Sickle Cell Disease, Transplantation, Pain Research, Regenerative Medicine, Clinical Trials and Supportive Activities, Anemia, Sickle Cell, Hematopoietic Stem Cell Transplantation, Humans, Quality of Life, Stem Cell Transplantation, United States, Cardiovascular medicine and haematology
Abstract

BackgroundSickle cell disease (SCD) is a life-limiting inherited hemoglobinopathy that results in significant complications and affects quality of life. Hematopoietic stem cell transplantation (HSCT) is currently the only curative intervention for SCD; however, guidelines are needed to inform how to apply HSCT in clinical practice.ObjectiveThese evidence-based guidelines of the American Society of Hematology (ASH) are intended to support patients, clinicians, and health professionals in their decisions about HSCT for SCD.MethodsThe multidisciplinary guideline panel formed by ASH included 2 patient representatives and was balanced to minimize potential bias from conflicts of interest. The Mayo Evidence-Based Practice Research Program supported the guideline development process, including performing systematic evidence reviews (through 2019). The panel prioritized clinical questions and outcomes according to their importance for clinicians and patients. The panel used the Grading of Recommendations Assessment, Development and Evaluation (GRADE) approach, including GRADE Evidence-to-Decision frameworks, to assess evidence and make recommendations, which were subject to public comment.ResultsThe panel agreed on 8 recommendations to help patients and providers assess how individuals with SCD should consider the timing and type of HSCT.ConclusionsThe evidence review yielded no randomized controlled clinical trials for HSCT in SCD; therefore, all recommendations are based on very low certainty in the evidence. Key recommendations include considering HSCT for those with neurologic injury or recurrent acute chest syndrome at an early age and to improve nonmyeloablative regimens. Future research should include the development of a robust SCD registry to serve as a comparator for HSCT studies.

Published
2021

15. Effect of donor type and conditioning regimen intensity on allogeneic transplantation outcomes in patients with sickle cell disease: a retrospective multicentre, cohort study

Author

Eapen, Mary, Brazauskas, Ruta, Walters, Mark C, Bernaudin, Françoise, Bo-Subait, Khalid, Fitzhugh, Courtney D, Hankins, Jane S, Kanter, Julie, Meerpohl, Joerg J, Bolaños-Meade, Javier, Panepinto, Julie A, Rondelli, Damiano, Shenoy, Shalini, Williamson, Joi, Woolford, Teonna L, Gluckman, Eliane, Wagner, John E, and Tisdale, John F

Subjects
Biomedical and Clinical Sciences, Cardiovascular Medicine and Haematology, Immunology, Transplantation, Hematology, Regenerative Medicine, Stem Cell Research, Rare Diseases, Orphan Drug, Clinical Research, Adolescent, Adult, Anemia, Sickle Cell, Blood Donors, Bone Marrow Transplantation, Child, Female, Fetal Blood, Graft vs Host Disease, Histocompatibility Testing, Humans, Male, Middle Aged, Peripheral Blood Stem Cell Transplantation, Progression-Free Survival, Proportional Hazards Models, Retrospective Studies, Survival Rate, Transplantation, Homologous, Young Adult, Cardiorespiratory Medicine and Haematology, Clinical Sciences, Cardiovascular medicine and haematology
Abstract

BackgroundDonors other than matched siblings and low-intensity conditioning regimens are increasingly used in haematopoietic stem cell transplantation. We aimed to compare the relative risk of donor type and conditioning regimen intensity on the transplantation outcomes of in patients with sickle cell disease.MethodsFor this retrospective cohort study, we collected data from 90 US centres reported to the Center for International Blood and Marrow Transplant Research. Eligible patients were younger than 50 years, had genetically confirmed sickle cell disease (Hb SS) or sickle beta thalassemia (Hb Sβ), and underwent allogeneic haematopoietic cell transplantation between Jan 15, 2008, and Dec 28, 2017. We considered transplants from donor-recipient pairs matched at the allele-level (HLA-A, HLA-B, HLA-C, and HLA-DRB1), including HLA-matched sibling donors, haploidentical related donors, matched unrelated donors, or mismatched unrelated donors. The main outcome was event-free survival. The effect of donor type, conditioning regimen intensity (myeloablative, non-myeloablative, and reduced-intensity regimens), age (≤12 or 13-49 years), sex, performance score, comorbidity index, recipient cytomegalovirus serostatus, graft type (bone marrow, peripheral blood, or umbilical cord blood), and transplantation period (2008-12 and 2013-17) on outcomes was studied using Cox regression models.FindingsOf 996 patients with sickle cell disease and who underwent transplantation in 2008-17, 910 (91%) were included (558 [61%] patients had HLA-matched sibling donors, 137 [15%] haploidentical related donors, 111 [12%] matched unrelated donors, and 104 [11%] mismatched unrelated donors). The median follow-up was 36 months (IQR 18-60) after transplantation from HLA-matched siblings, 25 months (12-48) after transplantation from haploidentical related donors, 37 months (23-60) after transplantation from HLA-matched unrelated donors, and 47 months (24-72) after transplantation from mismatched unrelated donors. Event-free survival was worse in recipients aged 13 years or older than in those younger than 13 years (hazard ratio 1·74, 95% CI 1·24-2·45; p=0·0014) and in those who received a transplant from haploidentical related donors (5·30, 3·17-8·86; p

Published
2019

18. The GIN-McMaster guideline tool extension for the integration of quality improvement and quality assurance in guidelines: a description of the methods for its development

Author

Piggott, Thomas, Langendam, Miranda W., Parmelli, Elena, Adolfsson, Jan, Akl, Elie A., Armstrong, David, Braithwaite, Jeffrey, Brignardello-Petersen, Romina, Brozek, Jan, Follmann, Markus, Kopp, Ina, Meerpohl, Joerg J., Neamtiu, Luciana, Nothacker, Monika, Qaseem, Amir, Rossi, Paolo Giorgi, Saz-Parkinson, Zuleika, van der Wees, Philip J., and Schünemann, Holger J.

Published
2023
Full Text
View/download PDF

23. An evaluation of the COVID-19 recommendation map identified diverging clinical and public health guidance

Author

Nasir, Zil H., Mertz, Dominik, Nieuwlaat, Robby, Santesso, Nancy, Lotfi, Tamara, Motilall, Ashley, Moja, Lorenzo, Mbuagbaw, Lawrence, Klugar, Miloslav, Turgeon, Alexis F., Mathew, Joseph L., Canelo-Aybar, Carlos, Pottie, Kevin, Dewidar, Omar, Langendam, Miranda W., Iorio, Alfonso, Vist, Gunn Elisabeth, Meerpohl, Joerg J., Flottorp, Signe, Kredo, Tamara, Piggott, Thomas, Mathews, Micayla, Qaseem, Amir, Chu, Derek K., Tugwell, Peter, Klugarová, Jitka, Nelson, Harrison, Hussein, Heba, Suvada, Jozef, Neumann, Ignacio, and Schünemann, Holger J.

Published
2022
Full Text
View/download PDF

30. Reporting quality of trial protocols improved for non-regulated interventions but not regulated interventions: A repeated cross-sectional study

Author

Lohner, Szimonetta, Gryaznov, Dmitry, von Niederhäusern, Belinda, Speich, Benjamin, Kasenda, Benjamin, Ojeda-Ruiz, Elena, Schandelmaier, Stefan, Mertz, Dominik, Odutayo, Ayodele, Tomonaga, Yuki, Amstutz, Alain, Pauli-Magnus, Christiane, Gloy, Viktoria, Bischoff, Karin, Wollmann, Katharina, Rehner, Laura, Meerpohl, Joerg J, Nordmann, Alain, Klatte, Katharina, Ghosh, Nilabh, Heravi, Ala Taji, Wong, Jacqueline, Chow, Ngai, Hong, Patrick Jiho, McCord, Kimberly, Sricharoenchai, Sirintip, Busse, Jason W., Agarwal, Arnav, Saccilotto, Ramon, Schwenkglenks, Matthias, Moffa, Giusi, Hemkens, Lars G., Hopewell, Sally, von Elm, Erik, Blümle, Anette, and Briel, Matthias

Published
2021
Full Text
View/download PDF

37. Predicting negative health outcomes in older general practice patients with chronic illness: Rationale and development of the PROPERmed harmonized individual participant data database

Author

González-González, Ana I., Dinh, Truc S., Meid, Andreas D., Blom, Jeanet W., van den Akker, Marjan, Elders, Petra J.M., Thiem, Ulrich, Kuellenberg de Gaudry, Daniela, Snell, Kym I.E., Perera, Rafael, Swart, Karin M.A., Rudolf, Henrik, Bosch-Lenders, Donna, Trampisch, Hans-Joachim, Meerpohl, Joerg J., Flaig, Benno, Kom, Ghainsom, Gerlach, Ferdinand M., Hafaeli, Walter E., Glasziou, Paul P., and Muth, Christiane

Published
2021
Full Text
View/download PDF

38. Research response to coronavirus disease 2019 needed better coordination and collaboration: a living mapping of registered trials

Author

Alawadhi, Solaf, Amer-Yahia, Sihem, Ávila, Camila, Bafeta, Aïda, Baudry, Julia, Bollig, Claudia, Bonnet, Hillary, Boutron, Isabelle, Bouet, Marinette, Cabanac, Guillaume, Chaimani, Anna, Chavalarias, David, Chen, Yaolong, Chevance, Astrid, Cohen-Boulakia, Sarah, Coquery, Emmanuel, Conil, Francoise, Davidson, Mauricia, De Nale, Laura, Devane, Declan, Diard, Elise, Doreau, Bastien, Evrenoglou, Theodoros, Fabri, Alice, Feron, Gilles, Ferrand, Gabriel, Fezeu, Leopold, Fouet, Mathilde, El Chall, Lina Ghosn, Graña, Carolina, Grasselli, Giacomo, Grolleau, François, Hacid, Mohand-Said, Haddy, Loubna, Hansen, Camilla, Hohlfeld, Ameer, Hróbjartsson, Asbjørn, Julia, Chantal, Mavridis, Dimitris, Meerpohl, Joerg J., Meyer, Brice, Naidoo, Nivantha, Thu, Van Nguyen, Oikonomidi, Theodora, Pienaar, Elizabeth, Quirke, Fiona, Rada, Gabriel, Ravaud, Philippe, Ripoll, Pierre, Riveros, Carolina, Rivière, Philippe, Sauvant, Marie, Schmucker, Christine, Toumani, Farouk, Tovey, David, Vuillemot, Romain, Xia, Jun, Yu, Xuan, Zoletic, Emina, Zweigenbaum, Pierre, Nguyen, Van Thu, and Barnier, Julien

Published
2021
Full Text
View/download PDF

39. A prognostic model predicted deterioration in health-related quality of life in older patients with multimorbidity and polypharmacy

Author

González-González, Ana I., Meid, Andreas D., Dinh, Truc S., Blom, Jeanet W., van den Akker, Marjan, Elders, Petra J.M., Thiem, Ulrich, De Gaudry, Daniela Küllenberg, Swart, Karin M.A., Rudolf, Henrik, Bosch-Lenders, Donna, Trampisch, Hans-Joachim, Meerpohl, Joerg J., Gerlach, Ferdinand M., Flaig, Benno, Kom, Ghainsom, Snell, Kym I.E., Perera, Rafael, Haefeli, Walter E., Glasziou, Paul P., and Muth, Christiane

Published
2021
Full Text
View/download PDF

40. Developing trustworthy recommendations as part of an urgent response (1–2 weeks): a GRADE concept paper

Author

Akl, Elie A., Morgan, Rebecca L., Rooney, Andrew A., Beverly, Brandiese, Katikireddi, Srinivasa Vittal, Agarwal, Arnav, Alper, Brian S., Alva-Diaz, Carlos, Amato, Laura, Ansari, Mohammed T., Brozek, Jan, Chu, Derek K., Dahm, Philipp, Darzi, Andrea J., Falavigna, Maicon, Gartlehner, Gerald, Pardo-Hernandez, Hector, King, Valerie, Klugarová, Jitka, Langendam, M.W. Miranda, Lockwood, Craig, Mammen, Manoj, Mathioudakis, Alexander G., McCaul, Michael, Meerpohl, Joerg J., Minozzi, Silvia, Mustafa, Reem A., Nonino, Francesco, Piggott, Thomas, Qaseem, Amir, Riva, John, Rodin, Rachel, Sekercioglu, Nigar, Skoetz, Nicole, Traversy, Gregory, Thayer, Kris, and Schünemann, Holger

Published
2021
Full Text
View/download PDF

45. A Reporting Tool for Practice Guidelines in Health Care: The RIGHT Statement.

Author

Chen, Yaolong, primary, Marušić, Ana, additional, Qaseem, Amir, additional, Meerpohl, Joerg J., additional, Flottorp, Signe, additional, Akl, Elie A., additional, Schünemann, Holger J., additional, Chan, Edwin S.Y., additional, Falck-Ytter, Yngve, additional, Ahmed, Faruque, additional, Barber, Sarah, additional, Chen, Chiehfeng, additional, Zhang, Mingming, additional, Xu, Bin, additional, Tian, Jinhui, additional, Song, Fujian, additional, Shang, Hongcai, additional, Tang, Kun, additional, Wang, Qi, additional, and Norris, Susan L., additional

Published
2023
Full Text
View/download PDF

46. ROB-ME: a tool for assessing risk of bias due to missing evidence in systematic reviews with meta-analysis

Author

Page, Matthew J, primary, Sterne, Jonathan A C, additional, Boutron, Isabelle, additional, Hróbjartsson, Asbjørn, additional, Kirkham, Jamie J, additional, Li, Tianjing, additional, Lundh, Andreas, additional, Mayo-Wilson, Evan, additional, McKenzie, Joanne E, additional, Stewart, Lesley A, additional, Sutton, Alex J, additional, Bero, Lisa, additional, Dunn, Adam G, additional, Dwan, Kerry, additional, Elbers, Roy G, additional, Kanukula, Raju, additional, Meerpohl, Joerg J, additional, Turner, Erick H, additional, and Higgins, Julian P T, additional

Published
2023
Full Text
View/download PDF

48. Bringing two worlds closer together: a critical analysis of an integrated approach to guideline development and quality assurance schemes

Author

Piggott, Thomas, Langendam, Miranda, Parmelli, Elena, Adolfsson, Jan, Akl, Elie A., Armstrong, David, Braithwaite, Jeffrey, Brignardello-Petersen, Romina, Brozek, Jan, Gore-Booth, Jolanta, Follmann, Markus, Leś, Zbigniew, Meerpohl, Joerg J, Neamţiu, Luciana, Nothacker, Monika, Qaseem, Amir, Giorgi Rossi, Paolo, Saz-Parkinson, Zuleika, van der Wees, Philip, and Schünemann, Holger J.

Published
2021
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results